-
Publication Date: February 25, 2008
To address the variance between agreed-upon standards of care and actual care provided by strengthening physician guidelines, we must overcome key barriers to adherence.
View More
-
Publication Date: February 25, 2008
Waste is pervasive in our health care system and must be eliminated by implementing key policy solutions.
View More
-
Publication Date: February 14, 2008
NEHI's CPOE study shows that one in ten patients at six representative community hospitals suffered a preventable medication injury and demonstrates how CPOE implementation dramatically decreases these errors
View More
-
Publication Date: March 1, 2007
Tele-ICUs address the shortage in supply of intensivists in intensive care units (ICUs) by enabling a relatively small number of intensivists to oversee the care of a large number of ICU patients.
View More
-
Publication Date: December 19, 2006
The Massachusetts Hospital CPOE Initiative is a groundbreaking and dynamic undertaking that has brought critical people in the state together to accelerate the adoption of this innovative technology.
View More
-
Publication Date: September 1, 2006
A group of chief information officers and project managers from Massachusetts hospitals currently implementing or planning to implement CPOE have identified six focus areas to improve implementation: physician incentives, process redesign, metrics, physician training, governance of clinical decision support and leadership commitment.
View More
-
Publication Date: January 1, 2006
Insulin analog drugs, used in combination therapy, are valuable and cost-effective for type 1 diabetes patients.
View More
-
Publication Date: March 1, 2005
CGM devices have potential to be highly valuable and cost-effective tools in managing diabetes.
View More
-
Publication Date: July 1, 2004
RPM provides substantial benefits to the health care system by reducing the number of hospital visits, length of stay and health care costs -- while improving quality of life -- for heart failure patients.
View More
-
Publication Date: March 1, 2004
The adoption of Gleevec, a pioneering drug in the treatment of CML, highlights challenges and opportunities in bringing drugs treating rare diseases to market.
View More